Sign in
4

Changes in Ownership

Ultragenyx Pharmaceutical Inc. Filed Acc 0001209191-23-016043

See Remarks sold 389 shares at $45.65 ($17,758)

  • See Remarks returned 10,599 shares (to the company)
  • See Remarks acquired 24,663 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Huang Dennis Karl See Remarks 2023-03-01 Grant or award +2,663 53,703 D: show line 1 in the form
Huang Dennis Karl See Remarks 2023-03-01 Grant or award +22,000 75,703 D: show line 2 in the form
Huang Dennis Karl See Remarks 2023-03-01 Sale −389 $45.65 $17,758 75,314 D: show line 3 in the form
Huang Dennis Karl See Remarks 2023-03-01 Returned to the company −10,599 $45.65 $483,844 64,715 D: show line 4 in the form
Open-market sales · 389 sh · avg $45.65 · $17,758

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Huang Dennis Karl See Remarks 2023-03-01 Grant or award · Stock Option (Right to Buy) +39,400 39,400 D: show line 5 in the form
Loading xslF345X03/doc4.xml…